More on LXRX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.50 |
|
|||
| Open | $0.50 | ||||
| 52 Wk High | $19.62 | ||||
| 52 Wk Low | $7.65 | ||||
| Day High | $0.53 | ||||
| Day Low | $0.50 | ||||
| P/E | N/A | ||||
| EPS | $-0.22 | ||||
| Volume | 2,671,184 | ||||
- Lexicon Pharma (LXRX) to Present at the 24th Annual Needham Virtual Healthcare Conference
- Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
- H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX)
- Form 8-K LEXICON PHARMACEUTICALS, For: Mar 27
- Lexicon Pharma (LXRX) Announces Exclusive License Agreement with Novo Nordisk for LX9851
- Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
- Form PRE 14A LEXICON PHARMACEUTICALS, For: Mar 20
- Form 10-K LEXICON PHARMACEUTICALS, For: Dec 31
- Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
- Lexicon Pharmaceuticals (LXRX) PT Lowered to $6 at Piper Sandler
Entities mentioned with LXRX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Needham & Company | View Related Stories »
- Citi | View Related Stories »
- Pre Market Movers | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
